NCT07043946 - A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2028

Conditions

Immune Thrombocytopenia (ITP)ITPBiologicsMonoclonalAnti-CD19

Interventions

DRUG

Budoprutug

Single IV dose of study product on Day 1 and Day 15

Trial Locations (8)

NOT_YET_RECRUITING

Climb Bio Investigative Site #381201, Belgrade

RECRUITING

Climb Bio Investigative Site #381202, Belgrade

RECRUITING

Climb Bio Investigative Site #381203, Novi Sad

RECRUITING

Climb Investigative Site #380204, Ivano-Frankivsk

RECRUITING

Climb Investigative Site #2380203, Kyiv

RECRUITING

Climb Investigative Site #380202, Kyiv

RECRUITING

Climb Investigative Site #380206, Kyiv

RECRUITING

Climb Investigative Site #380201, Lviv